The expression of V-ATPase is associated with drug resistance and pathology of non-small-cell lung cancer

Qiang Lü(Second Military Medical University), Xiaofei Li(Air Force Medical University), Sha Lu(Xian Central Hospital), Zhipei Zhang(Air Force Medical University), Ting Wang(Jilin University), Lijun Huang(Air Force Medical University), Chang Xi Zhou(Chinese PLA General Hospital), Yi Wan(Jiangnan University), Cunhai Zhang(117th Hospital of People's Liberation Army)
Diagnostic Pathology
August 28, 2013
10.1186/1746-1596-8-145
Cited by 67

Related Papers

Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma
|Cell Metabolism|2018|420
Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway
|Acta Pharmacologica Sinica|2016|182
Emerging agents that target signaling pathways in cancer stem cells
|Journal of Hematology & Oncology|2020|176
Elaiophylin, a novel autophagy inhibitor, exerts antitumor activity as a single agent in ovarian cancer cells
|Autophagy|2015|143
Evodiamine Improves Diet-Induced Obesity in a Uncoupling Protein-1-Independent Manner: Involvement of Antiadipogenic Mechanism and Extracellularly Regulated Kinase/Mitogen-Activated Protein Kinase Signaling
|Endocrinology|2007|130